Loading...
Dernières publications
-
Liem Nguyen, Maud Lemoine, Gibril Ndow, Zachary Ward, Timothy Hallet, et al.. Treat All versus targeted strategies to select HBV-infected people for antiviral therapy in The Gambia, west Africa: a cost-effectiveness analysis. The Lancet global health, 2024, 12 (1), pp.e66-e78. ⟨10.1016/S2214-109X(23)00467-9⟩. ⟨pasteur-04363873⟩
-
Luc Jaulmes, Youri Yordanov, Alexandre Descamps, Isabelle Durand-Zaleski, Aurélien Dinh, et al.. Effectiveness and Medicoeconomic Evaluation of Home Monitoring of Patients With Mild COVID-19: Covidom Cohort Study. Journal of Medical Internet Research, 2023, 25, pp.e43980. ⟨10.2196/43980⟩. ⟨hal-04142340⟩
-
Christiana Kartsonaki, J Kenneth Baillie, Noelia García Barrio, Joaquín Baruch, Abigail Beane, et al.. Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19. International Journal of Epidemiology, 2023, 52 (2), pp.355-376. ⟨10.1093/ije/dyad012⟩. ⟨hal-04164628⟩
-
Paul Loubet, Linda Wittkop, Laetitia Ninove, Mathieu Chalouni, Benoit Barrou, et al.. One-month humoral response following two or three doses of mRNA Covid-19 vaccines as primary vaccination in specific populations in France: first results from the ANRS0001S COV-POPART cohort. Clinical Microbiology and Infection, 2023, 29 (3), pp.388.e1-388.e8. ⟨10.1016/j.cmi.2022.10.009⟩. ⟨hal-03822592⟩
-
Jade Ghosn, Delphine Bachelet, Marine Livrozet, Minerva Cervantes-Gonzalez, Julien Poissy, et al.. Prevalence of Post-Acute COVID-19 Symptoms Twelve Months after Hospitalisation in Participants Retained in Follow-up: Analyses Stratified by Gender from a Large Prospective Cohort. Clinical Microbiology and Infection, 2023, 29 (2), pp.254.e7-254.e13. ⟨10.1016/j.cmi.2022.08.028⟩. ⟨hal-03801797⟩
Le CIC-1417 sur Twitter
Documents en texte intégral
70
Notices
67
Mots clés
Determinant
AstraZeneca vaccine
Respiratory syncytial virus
Dendritic cells
Clinical research
EMA
Cystic fibrosis
Covid-19
Déterminants
Care management
Efficacy
Diabetes mellitus type 2
Digital care
Antiretroviral therapy
Cohort
Innate immunity
Clinical trials
Epidemiology
Antiviral therapy
Conditional marketing authorization
Booster response
Drug
Disinformation
Sleep
Practices
Data sharing
COVID-19 vaccines
Attitude to health
Cancer
HIV
C-type lectin receptor
Catch-up
Clinical skills
Coronavirus
AIDS
Clinical practice
Acute kidney injury
Vaccine effectiveness
Dose escalation
Vaccine hesitancy
Adenoviral vector
Calcium phosphorus evaluation
Influenza-like illness
Chronic kidney disease
Delphi study
Determinants
Covidom
COVID-19
Dialysis
Incidence
EHealth literacy
Influenza
Adults
Adjuvant
Attitude
Misinformation
Risk factors
Awareness
1790GAHB F
Cost of illness
HPV vaccine
Effectiveness
Vaccination
Digital health intervention
Conjugate pneumococcal vaccine
Confidence
SARS-CoV-2
Biomarkers
B-lymphocytes
DMD
Cohort study
CERVICOVAGINAL SECRETIONS
Vaccine safety and efficacy
Attitudes
Adverse effects
Covid 19
Boys
AON
Internet
Immunocompromised
Vaccines
ANTIRETROVIRAL THERAPY
COCONEL cohort surveys
Chemotherapy
Antiviral agents
Healthcare workers
Vaccine
Immunization
Elderly
Assay
Co-morbidities
Hesitancy
Deletion
Attitudes of health personnel
Alpha variant
Coadministration
Immunogenicity
Vaccine acceptance
Antiviral
France